Patterns of relapse and progression in multiple myeloma patients after auto-SCT: Implications for patients' monitoring after transplantation Journal Article


Authors: Zamarin, D.; Giralt, S.; Landau, H.; Lendvai, N.; Lesokhin, A.; Chung, D.; Koehne, G.; Chimento, D.; Devlin, S. M.; Riedel, E.; Bhutani, M.; Babu, D.; Hassoun, H.
Article Title: Patterns of relapse and progression in multiple myeloma patients after auto-SCT: Implications for patients' monitoring after transplantation
Abstract: Auto-SCT (ASCT) is widely used in first-line treatment of multiple myeloma (MM). However, most patients eventually relapse or have progression of disease (R/POD). Although precise knowledge of R/POD patterns would be important to generate evidence-based surveillance recommendations after ASCT, such data is limited in the literature, especially after introduction of the free light chain assay (FLCA). This retrospective study examined the patterns of R/POD after first-line ASCT in 273 patients, using established criteria. At the time of R/POD, only 2% of patients had no associated serological evidence of R/POD. A total of 85% had asymptomatic R/POD, first detected by serological testing, whereas 15% had symptomatic R/POD with aggressive disease, early R/POD and short survival, with poor cytogenetics and younger age identified as risk factors. Although occult skeletal lesions were found in 40% of asymptomatic patients tested following serological R/POD, yearly skeletal surveys and urine testing were poor at heralding R/POD. We found a consistent association between paraprotein types at diagnosis and R/POD, allowing informed recommendations for appropriate serological monitoring and propose a new needed criterion using FLCA for patients relapsing by FLC only. Our findings provide important evidence-based recommendations that strengthen current monitoring guidelines after first-line ASCT in MM. © 2013 Macmillan Publishers Limited. All rights reserved.
Keywords: multiple myeloma; relapse; autologous transplantation; free light chain assay
Journal Title: Bone Marrow Transplantation
Volume: 48
Issue: 3
ISSN: 0268-3369
Publisher: Nature Publishing Group  
Date Published: 2013-03-01
Start Page: 419
End Page: 424
Language: English
DOI: 10.1038/bmt.2012.151
PROVIDER: scopus
PMCID: PMC3594539
PUBMED: 22890289
DOI/URL:
Notes: --- - "Export Date: 1 April 2013" - "CODEN: BMTRE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sergio Andres Giralt
    1050 Giralt
  2. Dmitriy Zamarin
    201 Zamarin
  3. Hani Hassoun
    329 Hassoun
  4. Guenther Koehne
    194 Koehne
  5. Heather Jolie Landau
    419 Landau
  6. Nikoletta Lendvai
    106 Lendvai
  7. Alexander Meyer Lesokhin
    363 Lesokhin
  8. David Chung
    240 Chung
  9. Sean McCarthy Devlin
    601 Devlin